Bunge Stock Could $134 by Year End, JPMorgan Analyst Says
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
Learn the key factors that contribute to a reliable dividend stock. Make informed investment choices for steady income.
20,247 articlesJPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
Eli Lilly is delivering big news for investors. The rallying force behind recent gains comes from GLP-1 drugs, manufa...
Westport's Q4 2025 earnings release offers clues about growth, margins, and cash flow. This article breaks down the t...
A major fund is doubling down on Lionsgate Studios as shares skyrocket. Learn what know about this bet, the strategy ...
A steep rally has many investors wondering if Intel is a steal or a trap. This guide breaks down the 168% swing in 20...
As June trading unfolds, Netflix nudges higher on pricing expectations ahead of its July earnings. The broader market...
Next week could push the stock market in new directions. Here are three essential signals plus practical moves to sta...
As inflation cools and rates hold, retirees are increasingly turning to preferred stock ETFs to secure steady, bond-l...
Tariffs are more than headlines—they touch everyday budgets and the stock market. This guide breaks down how trump's ...
American Express faced a notable decline as the market wrestled with AI fears and rate-cut speculation. This article ...
SpaceX's IPO is on the horizon, but you can gain exposure today through a strategic backdoor. This article explains w...
Investing in Micron today means evaluating AI-driven memory demand, pricing power, and the memory market cycle. This ...